Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,710.00
-160.00 (-2.73%)
At close: Dec 5, 2025

Hyundai Bioscience Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
1,96015,0509,4817,8529,24112,511
Upgrade
Other Revenue
--0-0---
Upgrade
Revenue
1,96015,0509,4817,8529,24112,511
Upgrade
Revenue Growth (YoY)
-87.61%58.73%20.76%-15.04%-26.14%-58.41%
Upgrade
Cost of Revenue
1,8793,2584,4905,1406,0126,104
Upgrade
Gross Profit
81.3411,7924,9922,7123,2296,408
Upgrade
Selling, General & Admin
10,0117,6407,8466,5426,6476,283
Upgrade
Research & Development
6,1253,0556,40116,4564,7631,968
Upgrade
Amortization of Goodwill & Intangibles
--328.42489.851,2282,185
Upgrade
Other Operating Expenses
33.8538.442.2527.3761.2840.98
Upgrade
Operating Expenses
16,60511,00114,79529,02312,51910,838
Upgrade
Operating Income
-16,524790.97-9,804-26,311-9,289-4,430
Upgrade
Interest Expense
-2,880-2,313-314.57-448.65-3,003-1,130
Upgrade
Interest & Investment Income
1,062210.7669.19536.69291.71195.91
Upgrade
Earnings From Equity Investments
-4,213-5,730-8,83493.911,542
Upgrade
Currency Exchange Gain (Loss)
27.483.73-68.6748.1520.39-102.31
Upgrade
Other Non Operating Income (Expenses)
733.9194.13-335.47-182.82-404.46-1,179
Upgrade
EBT Excluding Unusual Items
-21,793-6,944-9,853-17,524-12,291-5,104
Upgrade
Gain (Loss) on Sale of Investments
-168.8114.05123.67910.99--
Upgrade
Asset Writedown
---4,769--7,517-2,829
Upgrade
Pretax Income
-21,962-6,930-14,498-16,613-19,808-7,933
Upgrade
Income Tax Expense
2.78-1.04-805.47243.5326.46
Upgrade
Earnings From Continuing Operations
-21,965-6,930-14,499-15,807-20,051-8,260
Upgrade
Net Income
-21,965-6,930-14,499-15,807-20,051-8,260
Upgrade
Net Income to Common
-21,965-6,930-14,499-15,807-20,051-8,260
Upgrade
Shares Outstanding (Basic)
1208080797472
Upgrade
Shares Outstanding (Diluted)
1208080797472
Upgrade
Shares Change (YoY)
140.52%0.10%1.04%6.64%2.79%3.67%
Upgrade
EPS (Basic)
-183.29-87.02-182.26-200.77-271.58-115.00
Upgrade
EPS (Diluted)
-183.29-87.02-182.50-201.00-271.58-115.00
Upgrade
Free Cash Flow
-35,4112,087-6,548-18,087-4,285-17,702
Upgrade
Free Cash Flow Per Share
-295.5026.21-82.31-229.72-58.04-246.46
Upgrade
Gross Margin
4.15%78.35%52.65%34.53%34.95%51.22%
Upgrade
Operating Margin
-842.91%5.26%-103.40%-335.10%-100.52%-35.41%
Upgrade
Profit Margin
-1120.49%-46.04%-152.92%-201.33%-216.97%-66.02%
Upgrade
Free Cash Flow Margin
-1806.42%13.87%-69.06%-230.36%-46.37%-141.49%
Upgrade
EBITDA
-15,3681,425-8,369-24,529-6,586-652.3
Upgrade
EBITDA Margin
-9.47%-88.27%--71.27%-5.21%
Upgrade
D&A For EBITDA
1,156633.821,4351,7822,7033,778
Upgrade
EBIT
-16,524790.97-9,804-26,311-9,289-4,430
Upgrade
EBIT Margin
-5.26%-103.40%--100.52%-35.41%
Upgrade
Advertising Expenses
-267.64996.63965.591,497798.47
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.